Clarity in cell line development

Podcast | Planning a CLD Lab

Workflows, Clonality Assurance and New Tech

Following the postponement of the BioProcess International (BPI) US West Conference, Santa Clara in March 2020,  Duncan Borthwick speaks to Mark Stockdale about the talk he was due to give, “Total Cell Line Development – A Holistic A-Z Approach for Scientists Planning A CLD Lab”

Mark discusses the changes in Cell Line Development (CLD) workflows, clonality assurance and new technologies including transposases and cell growth factors which are shaping this area.

There are also references to Newton, tractors and sea sickness… so tune in!

Click on the image to download Mark’s supporting slides

CLD Clonality and New Tech

Mark Stockdale is a keen technology pathfinder working to amalgamate the technical and business functions. Mark worked as a Group Leader in Horizon Discovery Ltd, a scientist within Lonza Biologics, Cyclacel Ltd and started his career at Pfizer.

Duncan Borthwick is the Global Marketing Manager at Solentim. With a PhD from Edinburgh University, he has 20 years of biotech business experience.

For further information please contact [email protected]

This Podcast was recorded in the UK on 12th March 2020 and is 17 minutes long.

Translate »